Qubot raises $15M to advance magnetic surgical robot

What's the deal? Chinese medical robotics company QubotDealroom has a profile for this one. Try Dealroom → has raised US$13.8M in a Series A extension round. Noyu CapitalDealroom has a profile for this one. Try Dealroom → led the round, with participation from Pudong Venture CapitalDealroom has a profile for this one. Try Dealroom →, Pianzaihuang Yingke Fund, Tongyang Fund, and Taihu Aerospace Power Qimingxing.

What's the endgame? Qubot develops surgical robots that use magnetic control to guide a guidewire through blood vessels, helping doctors perform cerebrovascular surgery. The company will use the funds to secure regulatory approval, run clinical trials, and commercialise its automated magnetic-control interventional robot platform.

Why now? The company is pushing to bring its core product to market as it aims to automate interventional surgery. Bitola Capital is serving as its long-term exclusive financial adviser.

The signal: Investor appetite for surgical robotics remains strong in China, where startups are racing to automate complex procedures that today depend heavily on manual precision.

Image credit: NavyMedicine